...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands
【24h】

Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands

机译:新的c-myc G-四链体配体4-苯胺基喹唑啉衍生物的设计,合成和生物学评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of 4-anilinoquinazoline derivatives were designed and synthesized as novel c-myc promoter G-quadruplex binding ligands. Subsequent biophysical and biochemical evaluation demonstrated that the introduction of aniline group at 4-position of quinazoline ring and two side chains with terminal amino group improved their binding affinity and stabilizing ability to G-quadruplex DNA. RT-PCR assay and Western blot showed that compound 7a could down-regulate transcription and expression of c-myc gene in Hela cells, which was consistent with the behavior of an effective G-quadruplex ligand targeting c-myc oncogene. More importantly, RTCA and colony formation assays indicated that 7a obviously inhibited Hela cells proliferation, without influence on normal primary cultured mouse mesangial cells. Flow cytometric assays suggested that 7a induced Hela cells to arrest in G0/G1 phase both in a time dependent and dose-dependent manner. (C) 2016 Elsevier Masson SAS. All rights reserved.
机译:设计并合成了一系列4-苯胺基喹唑啉衍生物,作为新颖的c-myc启动子G-四链体结合配体。随后的生物物理和生化评估表明,在喹唑啉环的4位上引入苯胺基和两个带有末端氨基的侧链可提高它们对G-四链体DNA的结合亲和力和稳定能力。 RT-PCR和Western blot结果表明,化合物7a可以下调Hela细胞中c-myc基因的转录和表达,这与靶向c-myc癌基因的有效G-四链体配体的行为一致。更重要的是,RTCA和集落形成分析表明7a明显抑制了Hela细胞的增殖,而对正常的原代培养的小鼠肾小球系膜细胞没有影响。流式细胞仪检测表明7a诱导Hela细胞以时间依赖性和剂量依赖性方式停滞在G0 / G1期。 (C)2016 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号